Novel Macrolactams from a Deep-Sea-Derived <i>Streptomyces</i> Species

Four polyene macrolactams including the previously reported niizalactam C (<b>4</b>), and three new ones, streptolactams A–C (<b>1</b>–<b>3</b>) with a 26-membered monocyclic, [4,6,20]-fused tricyclic and 11,23-oxygen bridged [14,16]-bicyclic skeletons, respective...

Full description

Bibliographic Details
Main Authors: Pei Wang, Dongyang Wang, Rongxin Zhang, Yi Wang, Fandong Kong, Peng Fu, Weiming Zhu
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/19/1/13
Description
Summary:Four polyene macrolactams including the previously reported niizalactam C (<b>4</b>), and three new ones, streptolactams A–C (<b>1</b>–<b>3</b>) with a 26-membered monocyclic, [4,6,20]-fused tricyclic and 11,23-oxygen bridged [14,16]-bicyclic skeletons, respectively, were isolated from the fermentation broth of the deep-sea sediment-derived <i>Streptomyces</i> sp. OUCMDZ-3159. Their structures were determined based on spectroscopic analysis, X-ray diffraction analysis, and chemical methods. The abiotic formation of compounds <b>2</b> and <b>4</b> from compound <b>1</b> were confirmed by a series of chemical reactions under heat and light conditions. Compounds <b>1</b> and <b>3</b> showed a selective antifungal activity against <i>Candida albicans</i> ATCC 10231.
ISSN:1660-3397